Cipla Medpro (Pty) Ltd. (Cipla Medpro) is a privately held pharmaceutical company engaged in developing, manufacturing and commercializing generic medicines and branded pharmaceuticals. The product portfolio of the company consists of medicines for the treatment of the diseases in the areas of cardio-respiratory, diabetes, opthamology, gynecology, oncology, psychiatry and HIV/Aids. It also produces food supplements as well as OTC products for treating cold, flu, pain and allergy. In addition, Cipla Medpro develops veterinary medicines for dogs, cats, and horses. The company launched Ciplatrim, which contains the active ingredient sibutramine. Merck Sharpe & Dohme (MSD), has granted licences to Cipla-Medpro (Pty) Ltd. to export their generic versions of antiretroviral (ARV) drug Sustiva (efavirenz) and market them in South Africa. The company is headquartered in Bellville, South Africa.